Birth Defect: Clinical Trials

3 trials for Birth Defect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 unknown, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Active not recruiting 1, Unknown 1, Withdrawn 1

Follow Birth Defect: new trials by email Literature Review of Birth Defect trials Research Report on Birth Defect

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Trigeminal Nerve Blockade
Ropivacaine, Sham Comparator - Mouth Abnormalities, Cleft Palate
Phase 4Active not recruitingUniversity of Florida402018-11-202026-07-21
The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.
Gastrografin - Gastroschisis, Bowel Obstruction
Phase 4WithdrawnLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2018-08-032023-11-01
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
Tenofovir Disoproxil Fumarate (TDF) 300 mg oral daily. - Hepatitis B Infection, Congenital Malformation
Phase 4UnknownNew Discovery LLC2802018-06-102019-12-12

Narrower conditions

Congenital Abnormalities (3)  ·  Cleft Palate (1)  ·  Gastroschisis (1)  ·  Hepatitis B (1)  ·  Intestinal Obstruction (1)  ·  Mouth Abnormalities (1)  ·  Persistent Infection (1)  ·  Viremia (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Digestive System Diseases (2)  ·  Musculoskeletal Abnormalities (2)  ·  Musculoskeletal Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Craniofacial Abnormalities (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Gastrointestinal Diseases (1)  ·  Hepadnaviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Hernia (1)

Interventions

Diatrizoate (1)  ·  Diatrizoate Meglumine (1)  ·  Ropivacaine (1)  ·  Tenofovir (1)  ·  hepatitis B hyperimmune globulin (1)

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  New Discovery LLC (1)  ·  University of Florida (1)

Countries

Canada (1)  ·  China (1)  ·  United States (1)

Top investigators

Calvin Q Pan, MD (1)  ·  Cameron R Smith, MD, PhD (1)  ·  Erhei Dai, MD (1)

Results publications

PMID 39540799